BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22024512)

  • 1. Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma.
    Jang JW; Kwon JH; You CR; Kim JD; Woo HY; Bae SH; Choi JY; Yoon SK; Chung KW
    Antivir Ther; 2011; 16(7):969-77. PubMed ID: 22024512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
    Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
    J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
    Jang JW; Choi JY; Bae SH; Yoon SK; Woo HY; Chang UI; Kim CW; Nam SW; Cho SH; Yang JM; Lee CD
    Cancer; 2007 Oct; 110(8):1760-7. PubMed ID: 17724708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.
    Jang JW; Choi JY; Bae SH; Yoon SK; Chang UI; Kim CW; Cho SH; Han JY; Lee YS
    Hepatology; 2006 Feb; 43(2):233-40. PubMed ID: 16440357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
    Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y
    Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
    Jang JW; Choi JY; Bae SH; Kim CW; Yoon SK; Cho SH; Yang JM; Ahn BM; Lee CD; Lee YS; Chung KW; Sun HS
    J Hepatol; 2004 Sep; 41(3):427-35. PubMed ID: 15336446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
    Hui CK; Cheung WW; Au WY; Lie AK; Zhang HY; Yueng YH; Wong BC; Leung N; Kwong YL; Liang R; Lau GK
    Gut; 2005 Nov; 54(11):1597-603. PubMed ID: 16000641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.
    Xia F; Lai EC; Lau WY; Ma K; Li X; Bie P; Qian C
    Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW; Park KW; Cho SH; Park HS; Lee WJ; Lee DH; Kim CM
    Am J Gastroenterol; 2005 Oct; 100(10):2194-200. PubMed ID: 16181368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.
    Hung IF; Poon RT; Lai CL; Fung J; Fan ST; Yuen MF
    Am J Gastroenterol; 2008 Jul; 103(7):1663-73. PubMed ID: 18616655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High hepatitis B virus DNA level in serum before liver transplantation increases the risk of hepatocellular carcinoma recurrence.
    Li MR; Chen GH; Cai CJ; Wang GY; Zhao H
    Digestion; 2011; 84(2):134-41. PubMed ID: 21502763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
    Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
    J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH; Park JW; Kim TH; Koh DW; Lee WJ; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):813-9. PubMed ID: 17524569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.